Medical Conditions
   Abdominal Pain, Recurrent
   Acute Lymphoblastic Leukemia
   Acute Otitis Media
   Acute Strep Throat
   Atopic Dermatitis (Eczema)
   Attention-Deficit Hyperactivity Disorder
   Attention-Deficit Hyperactivity Disorder (ADHD)
   Breast Enlargement, Premature
   Breath-Holding Spells
   Care of the Premature Infant
   Celiac Disease
   Chickenpox Immunization
   Coarctation of the Aorta
   Congenital Hip Dysplasia
   Coxsackie A16
   Cyclic Vomiting Syndrome (CVS)
   Developmental Dysplasia of the Hip
   Diabetic Mother, Infant of
   Ear Infection
   Eating Disorders
   Enlarged Lymph Nodes
   Erythema Multiforme
   Eye Problems Related to Headache
   Febrile Seizure
   Fetal Alcohol Syndrome
   Fifth Disease (Erythema Infectiosum)
   Food Born Illnesses
   Fragile X Syndrome
   Gastroenteritis, Viral
   Gastroesophageal Reflux
   Hand Foot and Mouth
   Head Lice
   Headache Related to Eye Problems
   Hepatitis A
   Hepatitis A Immunization
   Hepatitis B
   Hepatitis B Immunization
   Hepatitis C
   Hib Immunization
   High Blood Pressure
   Infant of a Diabetic Mother
   Infectious Mononucleosis
   Influenza Immunization
   Kawasaki Syndrome
   Language Development in Young Children
   Lead Poisoning
   Lung Hypoplasia
   Lyme Disease
   Mental Health
   MMR Immunization
   Obesity in Childhood
   Otitis Media, Acute
   Pneumococcal Conjugate Immunization
   Polio Immunization
   Premature Thelarche
   Prematurity, Retinopathy of
   Pulmonary Hypertension
   Pulmonary Hypertension (PPH & SPH)
   Retinopathy of Prematurity
   Rheumatic Fever, Acute
   Ringworm (Tinea)
   Rubella (German Measles)
   Separation Anxiety
   Speech Development in Young Children
   Stevens-Johnson Syndrome
   Strep Throat-Acute
   Strep Throat-Recurrent
   Stuttering and the Young Child
   Swine Flu
   Swine Flu (H1N1) FAQ
   Swine Flu (H1N1) Vaccine
   Swollen Glands
   Tear Duct, Blocked
   Tetralogy of Fallot
   Thyroid Problems
   Tinea (ringworm infection)
   Toxic Shock Syndrome
   Turner Syndrome
   Underdeveloped Lungs
   Urinary Tract Infection
   Varicella or Chickenpox
   Varivax Immunization
   Vesicoureteral Reflux
   Wilson Disease
New Parents
Special Needs
Web Links
What's Going Around?
Visual Symptom Checker


Medical Conditions

Lung Hypoplasia

Reese H. Clark, M.D.
Director of Research
Pediatrix Medical Group, Inc.
Fort Lauderdale, Florida

What is Lung Hypoplasia?

In general terms lung hypoplasia means under developed lungs. Hypo means small, plasia means formed. The lungs are a vital organ and without them we can not live. The lung is made up of small gas exchange units called alveoli. Alveoli are thin walled structures that are surrounded by small veins and arteries called capillaries. Gas in the alveoli is exchanged with gas in the blood allowing oxygen to be delivered to tissue as a key element for body function and carbon dioxide to be eliminated from the body.

When the lung is hypoplastic the number of alveoli that are available for gas exchange are decreased. If the lungs are very hypoplastic the number of gas exchange units reaches a critically low level and adequate gas exchange can not be maintained. Newborn babies with very hypoplastic lungs die of lung failure in the first few days of life if they cannot be supported long enough to grow more lung.


What Causes Lung Hypoplasia?

The lung begins forming very early in fetal development. Any thing that restricts growth of the chest can cause the lung to be under developed. It is important to distinguish lung hypoplasia from lung immaturity. They are not the same things though, functionally, they have the same effect. Both lead to inadequate gas exchange and lung failure. Babies born prematurely have immature lungs with a developmental normal number of alveoli. The goal in caring for these babies is to support them in a manner that prevents injury to the lung. If injury is avoided these babies can have normal lung development.

In contrast events that impact fetal lung growth may effect future lung growth and may prevent babies with lung hypoplasia from ever developing a normal complement of alveoli.

The most common causes of poor fetal lung growth are: inadequate amniotic fluid, congenital diaphragmatic hernia, hydrops fetalis, certain types of dwarfism, pulmonary agenesis, cystic adenomatous formation, and cystic hydroma. In each of these anomalies, the fetal lung does not grow to its normal size. Inadequate amniotic fluid is most commonly due to early leaking of amniotic fluid due to premature rupture of the membranes that surround the fetus. This is known as oligohydramnios (too little amniotic fluid). If amniotic fluid leaks out from around the baby, the chest wall movement that occurs with fetal breathing may be restricted. Fetal breathing and adequate fluid pressure are both believed vitally important for normal lung development.

The second most common cause for inadequate amniotic fluid is fetal renal anomalies. Amniotic fluid is produced by the amniotic membranes and by the fetal kidneys. Severe abnormalities of the kidneys (eg. polycystic kidneys, hydronephrosis, renal agenesis) can cause too little amniotic fluid to be formed (oligohydramnios) and are commonly associated with lung hypoplasia. Babies with kidney and lung problems have a particularly grave prognosis because they have two organ systems that have failed.

Structural problems in development may also impair lung growth. In babies with congenital diaphragmatic hernia, the diaphragm that separates the lung form the abdomen fails to develop. As a consequence, the intestines move into the chest cavity and restrict lung growth. Similarly, certain types of dwarfism or congenital anomalies of the lung restrict the area in which the lungs can grow normally. While most of these anomalies are rare (1:3000), they are commonly life threatening.


Who Gets It?

  1. Babies born to mothers with prolong rupture of amniotic membranes and oligohydramnios.
  2. Newborns with severe renal anomalies, born to mother with resultant oligohydramnios.
  3. Newborns with certain congenital anomalies
    • Congenital diaphragmatic hernia
    • Thanatophoric dwarfism
    • Cystic hydroma
    • Cystic adenomatosis malformation
  4. Newborns with hydrops fetalis
  5. Newborns with neuromuscular diseases


How does it cause disease?

Small lungs fail to accomplish normal gas exchange (oxygen in, carbon dioxide out.)


Common Findings

The presentation is variable and dependent on the severity of the hypoplasia. Some babies may present with mild tachypnea (fast breathing) others may have signs of severe respiratory failure: fast breathing, labored breathing, blue color, and gasping.



The most important factors leading to a diagnosis are: history of fetal anomalies associated with lung hypoplasia, history of mom having too little amniotic fluid, and a chest radiograph showing small lungs.



Currently, treatment is primarily supportive. This means that there is currently no available medicine that makes babies grow lungs. So, until lung growth occurs to an extent that the lung can support normal gas exchange, the babies must be supported by artificial means. The main problem is that all modes of artificial respiratory support are associated with lung injury. The trick is to support normal gas exchange without causing injury and to support good nutrition so that the lung can grow. Babies have an incredible capacity to grow and develop. In time, if the lung is not too underdeveloped the baby can usually wean off artificial support and go home. Therapies used to support gas exchange in order of level of support are: oxygen, assisted ventilation, high frequency ventilation, and extracorporeal membrane oxygenation (ECMO).



There are no methods for preventing babies with certain anomalies from developing lung hypoplasia. Research is currently focused on maintaining normal amniotic fluid and pressure and prevention of restriction of lung growth. Investigators are also looking at factors that promote normal lung growth. The hope is that neonates with lung hypoplasia might be treated with lung growth factors that would promote growth of normal lung, reduce the need for artificial support and its attendant propensity to cause injury and allow for a healthier life.


About the Author

Dr. Clark, a leading clinical researcher for the care of critically ill newborns, is the Director of Research for Pediatrix Medical Group, Inc. and a Consulting Associate Professor at Duke University.

A native of North Carolina, Dr. Clark earned both his Bachelor of Arts and medical degrees from the University of North Carolina at Chapel Hill. He completed his pediatrics residency and his neonatal fellowship at Wilford Hall United States Air Forces Medical Center. He is a board-certified pediatrician and neonatologist.

Copyright 2012 Reese H. Clark, M.D., All Rights Reserved

Health Center

Select from over 100 symptoms to learn about managing your child's illness.